Similar findings were produced in NSCLC, where CFTR inhibition activated the uPA/uPAR pathway and generated changes in cell morphology, downregulation of E-cadherin and upregulation of vimentin and fibronectin [169]. This evidence concerns the gene CFTR and non-small cell lung carcinoma.